Haemonetics to Buy Assets of Pall, Hemerus Medical

Haemonetics Corp. said it agreed to acquire the blood collection and filtration assets of Pall Corp. for approximately $551 million, and separately agreed to buy certain assets of Hemerus Medical LLC, a Minnesota-based company that develops technologies for the collection of whole blood, and processing and storage of blood components.

Haemonetics agreed to pay Pall $551 million, of which $536 million will be paid upon closing and the remaining $15 million paid for additional assets to be delivered by 2016, the statement said. Haemonetics said $475 million will be new borrowings and $61 million will be from existing cash holdings.

Haemonetics did not disclose the purchase price for the property of Hemerus.

(Corrects to show two transactions.)
Before it's here, it's on the Bloomberg Terminal. LEARN MORE